UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by UNIVEST FINANCIAL Corp

UNIVEST FINANCIAL Corp lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.0% during the second quarter, Holdings Channel reports. The firm owned 8,565 shares of the healthcare conglomerate’s stock after selling 179 shares during the period. UnitedHealth Group makes up approximately 1.2% of UNIVEST FINANCIAL Corp’s investment portfolio, making the stock its 25th largest position. UNIVEST FINANCIAL Corp’s holdings in UnitedHealth Group were worth $4,362,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Bell Investment Advisors Inc raised its stake in shares of UnitedHealth Group by 4.8% during the 4th quarter. Bell Investment Advisors Inc now owns 525 shares of the healthcare conglomerate’s stock worth $276,000 after buying an additional 24 shares during the last quarter. Harbor Investment Advisory LLC raised its stake in shares of UnitedHealth Group by 3.2% during the 1st quarter. Harbor Investment Advisory LLC now owns 35,946 shares of the healthcare conglomerate’s stock worth $17,783,000 after buying an additional 1,129 shares during the last quarter. Austin Private Wealth LLC grew its holdings in shares of UnitedHealth Group by 9.8% during the first quarter. Austin Private Wealth LLC now owns 1,246 shares of the healthcare conglomerate’s stock worth $573,000 after buying an additional 111 shares in the last quarter. Vanguard Personalized Indexing Management LLC boosted its position in UnitedHealth Group by 7.9% during the fourth quarter. Vanguard Personalized Indexing Management LLC now owns 75,602 shares of the healthcare conglomerate’s stock worth $39,802,000 after acquiring an additional 5,537 shares during the last quarter. Finally, Capital Insight Partners LLC boosted its holdings in shares of UnitedHealth Group by 3.8% during the first quarter. Capital Insight Partners LLC now owns 9,045 shares of the healthcare conglomerate’s stock worth $4,475,000 after purchasing an additional 332 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analysts Set New Price Targets

UNH has been the topic of a number of recent analyst reports. Truist Financial lifted their price target on shares of UnitedHealth Group from $600.00 to $640.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. Robert W. Baird boosted their price objective on shares of UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 17th. Baird R W raised shares of UnitedHealth Group to a “strong-buy” rating in a research report on Thursday, May 30th. Cantor Fitzgerald restated an “overweight” rating and set a $591.00 price objective on shares of UnitedHealth Group in a research note on Monday, August 19th. Finally, Wells Fargo & Company boosted their price target on UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. One investment analyst has rated the stock with a hold rating, nineteen have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Buy” and a consensus target price of $614.17.

Insider Buying and Selling

In related news, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at $16,812,029.88. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In related news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the sale, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Price Performance

UNH opened at $597.64 on Friday. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $607.94. The stock has a fifty day moving average price of $558.98 and a 200 day moving average price of $515.15. The stock has a market cap of $551.87 billion, a price-to-earnings ratio of 36.53, a PEG ratio of 1.68 and a beta of 0.58. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The firm had revenue of $98.86 billion during the quarter, compared to the consensus estimate of $98.73 billion. During the same quarter in the prior year, the company earned $6.14 EPS. The firm’s revenue for the quarter was up 6.4% compared to the same quarter last year. Analysts forecast that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be issued a dividend of $2.10 per share. The ex-dividend date is Monday, September 16th. This represents a $8.40 annualized dividend and a yield of 1.41%. UnitedHealth Group’s dividend payout ratio is currently 51.34%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.